France Archives

seasonal influenza universal vaccine sanofi peptcell seek niaid nihr

News and Trends 12 Nov 2015

Sanofi’s COBRA Research to Tackle the Challenge of A Universal Influenza Vaccine for Winter

Sanofi Pasteur is the infectious disease division of the French Giant Sanofi, responsible for producing 1 Billion vaccine doses each year. Now they are looking to ‘evolve’ the vaccine R&D field, adapting their approach to find a broader spectrum defense against seasonal Influenza strains. However, the UK NIHR and PepTCell are also after the same […]

November 12, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 11 Nov 2015

French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients

Onxeo is the French orphan-drug specialist in Oncology who has various pipelines for certain cancers. Now their phase I clinical trial of belinostat (trade name Beleodaq) combined with chemo for relapses in non-Hodgkin Lymphomas has shown an 89% response rate. Originally developed by TopoTarget (a biotech in Copenhagen) Belinostat is now under Onxeo’s portfolio (along […]

November 11, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 10 Nov 2015

The 10 Hottest Bioincubators in Europe

A Bioincubator is a launch-pad structure for entrepreneurs to make their project in the sciences real. In Europe, we have many incubators within each industry, responsible for strategic investment, development and providing a support network for start-ups. Bioincubators are considered as the first ‘home’ for young biotech companies, providing entrepreneurs access to research laboratories, technology platforms, specific […]

November 10, 2015 - 5 minutesmins - By Nicolas Sainte-Foie

News and Trends 9 Nov 2015

A Group of French Medics are Questioning the Fastest-Growing Big Biotech in the World…

Approved drugs can always show bad signs once injected massively. Four physicians from Paris sent a letter to the New England Journal of Medicine to report that Gilead’s Hepatitis C blockbuster drug, Sovaldi, can cause abnormally slower heart rates and risks of Heart Failure… The French Physicians report used data based on 415 patients treated […]

November 9, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 9 Nov 2015

This French Biotech has a ‘Super-Insulin’ up its Diabetes Sleeve

Human insulin produced in Bacteria is already a miracle for Diabetes…but sometimes, it’s not as efficient as it could be. The French Biotech Adocia is developing a super-insulin and showed successful efficiency data in a early-stage human trials. Adocia is a Lyon-based Biotech we have discussed before. Even if its logo is a bit strange […]

November 9, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 6 Nov 2015

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

About 30%. That’s how Cellectis‘ NASDAQ stock price has jumped between the 4th and the 5th of November. But why? Basically, because of the first human success of their allogeneic CAR-T therapy! The Great Ormond Street Hospital (UK) treated a young patient with refractory relapsed Acute Lymphoblastic Leukemia (ALL) with Cellectis’ allogeneic UCART19 product candidate in June. To […]

November 6, 2015 - 2 minutesmins - By Jerome Topsent

News and Trends 4 Nov 2015

€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech

Sanofi is now the latest Biotech lining up to partner with BioNTech from Mainz (Germany), for license of their mRNA Immuno-oncology platform in a€1.37Bn long-term development deal. Novel mRNA targets in Immuno-onology is a top-shelf cancer R&D area, with Germany’s CureVac also attracting another €100M yesterday for their mRNA platform (which targets lung and prostate […]

November 4, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 3 Nov 2015

History of Biotech: 25 Years of The Human Genome Project

The birth of the Human Genome Project was now 25 years ago (woah!)…What was the HGP’s significance to biotech? What? The Human Genome Project (HGP) was an international effort with a primary goal; to sequence the entire genetic code of a whole organism (Humans…). It today remains the largest ever world collaborative project, which thrust the […]

November 3, 2015 - 5 minutesmins - By Marie Godar

News and Trends 2 Nov 2015

A Glimpse into the DIY Biotech Movement: Biohacking, Vegan Cheese, Algae Beer and Bacterial Art!

Fab Labs have become hugely fashionable since 2010… But what about Bio Fab Labs? Have you ever thought about sharing your RNA or DNA amplification equipment? It can be a massive help for entrepreneurs or students, and Bio Fab Labs are starting to emerge in backyards across the world for Education, Innovation and even creative SynBio art. This new era of DIY […]

November 2, 2015 - 6 minutesmins - By Julie Lellouche

News and Trends 2 Nov 2015

The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too

So, we all know the CRISPR Success story with Emmanuelle Charpentier & Jennifer Doudna, who have received multiple awards and constant celebration of their pioneering work in 2012. However, what about the guy who really first described the CRISPR-Cas9 mechanism all the way back in 2007? Finally, he gets some recognition too. Senior DuPont scientist […]

November 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 29 Oct 2015

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

Cellectis is a leader in immuno-oncology CAR-T therapies from France, which might revolutionise cancer treatments. Now, the next step in the CAR-T campaign is to step away from personalised (autologous) therapies, which are time-consuming and expensive, to instead produce an allogenic version available to all. So, what is CAR-T? You can read a more in-depth […]

October 29, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2015

Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease

Karen Aiach had no background in science or the biotech industry, yet when her daughter Ornella was diagnosed with the super-rare Sanfilippo syndrome this inspired her to co-found and become the CEO of Lysogene, today a clinical-stage biotech based in Paris, France. Now Ornella is participating in the ongoing clinical trials for a new gene […]

October 27, 2015 - 7 minutesmins - By Dani Bancroft

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us